Analyst
RBC
Equibles does not estimate personal net worth.
Shagan Singh is recorded as Analyst at RBC. Shagan Singh has spoken on 3 earnings calls and 1 other investor event across 3 companies, most recently for Boston Scientific Corp on March 28, 2026. Those appearances were for Teleflex Inc (TFX), Boston Scientific Corp (BSX) and Stryker Corp (SYK). The companies whose calls Shagan Singh spoke on are classified in the Healthcare sector.
“I was just wondering with respect to next steps, how should we think about guideline changes, label changes, and then, you know, what impact do you expect from the study in 2026 prior to these label changes in NCD?”
“One on Mako, you guys shared some metrics, two-third, one-third of knees and hips on Mako, and then utilization rate, 50% and 20% respectively. Where do you think these metrics go over time and what are the key drivers there?”
“I guess a couple of clarification questions. So just on Q2 EPS beat, can you maybe help us identify how much was tariff versus business outperformance, phasing for EPS or margins in Q3 versus Q4?”
“I guess I was hoping you could comment a little bit on your 2025 guidance of 1% to 2% constant currency, which surprised me a little bit. What has driven such a drastic revision in your business?”
RBC
Analyst
Transcript header (unverified)
TFX
Medical Instruments & Supplies · Healthcare
SYK
Medical Devices · Healthcare
